All Business articles
View all stories of the same content type.
-
BusinessEurope gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
Business
UK firms face critical lab space shortage
Growing chemistry companies hit a wall when it comes to expanding their labs
-
Business
European chemicals industry struggling to compete as costs surge
BASF plans major cost cuts as energy crisis saps profits
-
Business
Mallinckrodt ordered to clean up US river mercury pollution
Firm must set at least $187 million in trust to pay for Penobscot river remediation
-
Business
Contaminated cough syrup linked to 66 child deaths in The Gambia
Medicines made by Indian generics firm Maiden Pharmaceuticals have been blamed for acute kidney injuries
-
Business
Setting the standard for calculating indirect emissions
Industry collaboration creates carbon footprinting guidelines for chemical products
-
Business
Alzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
Business
Silky smooth tissue regeneration
Serigen mediproducts is harnessing one of India’s biggest industries to help heal wounds and rebuild flesh and bone
-
Business
An evolution in pharma outsourcing
Contract services firms are becoming increasingly sophisticated and embedded in the ecosystem of drug development
-
Business
Arrayit chief convicted of fraud over blood testing
Mark Schena misrepresented the company’s value to investors and defrauded public and private insurers
-
Business
Nature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
-
Business
Fatal hydrogen sulfide leak at US waste treatment plant
One worker killed and four others injured at US Ecology site in Ohio
-
Business
Rocket-powered carbon dioxide conversion
Barton Blakeley is lowering the carbon footprint of silica and other materials
-
Business
J&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
-
Business
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Business
UK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
-
Business
Chemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’
-
Business
Gas shortage puts pressure on chemical feedstocks
Demand for fuels has constricted European supplies, pushing up prices and threatening rationing
-
Business
Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
Business
California advances plans to make its own insulin
Governor commits $100 million to develop low-cost insulin and build manufacturing facility to strengthen drug’s supply chain
